Adult height predictions for Constitutional Growth Delay, growth hormone treatment for idiopathic short stature and the FDA: are they related?
Rapaport
Robert
R
Mount Sinai Diabetes Center, Mount Sinai School of Medicine, New York, NY 10029, USA. robert.rapaport@msnyuhealth.org
D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology*; D001827:Body Height / Q000502:physiology*; D003627:Data Interpretation, Statistical; D006130:Growth Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013006:Growth Hormone / Q000627:therapeutic use*; D006287:Health Planning Guidelines; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D011379:Prognosis; D011628:Puberty, Delayed / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration
D013006:Growth Hormone